Form 4 for LUNG Pulmonx Corp
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001670118-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | 2025-12-01 | LUNG | Sung Derrick | COO, CFO | A - Grant | $0.00 | +1.20M | 1.34M | +887% | $0 |
| D | 2025-12-03 | 2025-12-01 | LUNG | Sung Derrick | COO, CFO | A - Grant | $0.00 | +400.0K | 400.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | A | A | 1,200,000 | $0.00 | 1,335,319 | D | — | — | (F1) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant. |
| 2 | Derivative | Performance Stock Units | 2025-12-01 | A | A | 400,000 | $0.00 | 400,000 | D | — · — to 2028-12-01 | 400,000 Common Stock | (F2) Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments. |